(Reuters) – Drugmaker AstraZeneca on Monday its COVID-19 vaccine, Vaxzevria, has been approved in the European Union by the region’s medical regulator as a third-dose booster in adults following a panel recommendation last week.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Sherry Jacob-Phillips)
